首页> 外文期刊>Journal of Controlled Release: Official Journal of the Controlled Release Society >A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers. I. Manipulation Of drug release using Eudragit L100-55 and Eudragit S100 combinations.
【24h】

A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers. I. Manipulation Of drug release using Eudragit L100-55 and Eudragit S100 combinations.

机译:使用甲基丙烯酸共聚物的pH依赖性结肠靶向口服药物递送系统。 I.使用Eudragit L100-55和Eudragit S100组合操纵药物释放。

获取原文
获取原文并翻译 | 示例
       

摘要

Lactose-based placebo tablets were coated using various combinations of two methacrylic acid copolymers, Eudragit L100-55 and Eudragit S100, by spraying from aqueous systems. The Eudragit L100-55-Eudragit S100 combinations (w/w) studied were 1:0, 4:1, 3:2, 1:1, 2:3, 1:4, 1:5 and 0:1. The coated tablets were tested in vitro for their suitability for pH dependent colon targeted oral drug delivery. The same coating formulations were then applied on tablets containing mesalazine as a model drug and evaluated for in vitro dissolution rates under various conditions. The disintegration data obtained from the placebo tablets demonstrate that disintegration rate of the studied tablets is dependent on: (i) the polymer combination used to coat the tablets, (ii) pH of the disintegration media, and (iii) the coating level of the tablets. Dissolution studies performed on the mesalazine tablets further confirmed that the release profiles of the drug could be manipulated by changing the Eudragit L100-55 and Eudragit S100 ratios within the pH range of 5.5 to 7.0 in which the individual polymers are soluble respectively, and a coating formulation consisting of a combination of the two copolymers can overcome the issue of high gastrointestinal (GI) pH variability among individuals. The results also demonstrated that a combination of Eudragit L100-55 and Eudragit S100 can be successfully used from aqueous system to coat tablets for colon targeted delivery of drugs and the formulation can be adjusted to deliver drug at any other desirable site of the intestinal region of the GI tract on the basis of pH-variability. For colon targeted delivery of drugs the proposed combination system is superior to tablets coated with either Eudragit L100-55 or Eudragit S100 alone.
机译:使用两种甲基丙烯酸共聚物Eudragit L100-55和Eudragit S100的各种组合,通过从水性体系中喷雾,将基于乳糖的安慰剂片剂包衣。研究的Eudragit L100-55-Eudragit S100组合(w / w)为1:0、4:1、3:2、1:1、2:3、1:4、1:5和0:1。体外测试了包衣片剂对pH依赖性结肠靶向口服药物递送的适用性。然后将相同的包衣制剂涂在含有美沙拉嗪作为模型药物的片剂上,并评估各种条件下的体外溶出速率。从安慰剂片剂获得的崩解数据表明,所研究片剂的崩解速率取决于:(i)用于包衣片剂的聚合物组合,(ii)崩解介质的pH值,以及(iii)片剂的包衣水平平板电脑。对美沙拉嗪片剂进行的溶出度研究进一步证实,可以通过在单独的聚合物分别可溶于的5.5至7.0的pH范围内改变Eudragit L100-55和Eudragit S100的比例来控制药物的释放特性,由两种共聚物组合而成的配方可以克服个人之间高胃肠道(GI)pH变异性的问题。结果还表明,Eudragit L100-55和Eudragit S100的组合可以成功地从水性系统中包衣以用于结肠靶向递送药物的片剂,并且可以调整制剂以在肠的肠道区域的任何其他所需位置递送药物根据pH值变化的胃肠道。对于结肠靶向给药,建议的组合系统优于单独涂覆Eudragit L100-55或Eudragit S100的片剂。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号